As demonstrated in Fig. 3, OLFML2B expression in protein level was examined using IHC, the results showed that OLFML2B was overexpressed in 9 (69.23%) of 13 patients with gastric carcinoma and downregulated in 4 (30.77%) of 13 patients. Here, OLFML2B is linked to gastric carcinoma.